These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1863643)
21. Nondevelopmental research on human subjects: the impact of the recommendations of the National Commission. Levine RJ Fed Proc; 1977 Sep; 36(10):2359-64. PubMed ID: 892005 [No Abstract] [Full Text] [Related]
22. Problems of drug testing in children in the United States. Yaffe SJ Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147 [No Abstract] [Full Text] [Related]
23. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
25. The standard of disclosure in human subject experimentation. Morin K J Leg Med; 1998 Jun; 19(2):157-221. PubMed ID: 9658739 [No Abstract] [Full Text] [Related]
26. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics. Pediatrics; 1995 Feb; 95(2):286-94. PubMed ID: 7838651 [No Abstract] [Full Text] [Related]
27. An IRB member's perspective on access to innovative therapy. Moore DL Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854 [No Abstract] [Full Text] [Related]
28. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
29. Regulating research on the terminally ill: a proposal for heightened safeguards. Addicott DC J Contemp Health Law Policy; 1999; 15(2):479-524. PubMed ID: 10394764 [No Abstract] [Full Text] [Related]
30. New rules for new drugs: the challenge of AIDS to the regulatory process. Edgar H; Rothman DJ Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413 [TBL] [Abstract][Full Text] [Related]
31. The regulation of human experimentation in the United States--a personal odyssey. Katz J IRB; 1987; 9(1):1-6. PubMed ID: 11649890 [No Abstract] [Full Text] [Related]
32. Bioethics group divided over research on mentally ill. Weiss R Washington Post; 1998 Nov; ():A6. PubMed ID: 11648074 [No Abstract] [Full Text] [Related]
33. Special informed consent requirements are included in protocol review procedures. Maloney DM Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274 [No Abstract] [Full Text] [Related]
34. Panel backs gene transplant for cancer treatment test. Leary WE N Y Times Web; 1988 Oct; ():A1, C9. PubMed ID: 11646704 [No Abstract] [Full Text] [Related]
35. Balancing moral principles in federal regulations on human research. Ackerman TF IRB; 1992; 14(1):1-6. PubMed ID: 11652041 [No Abstract] [Full Text] [Related]
36. Cognitively impaired subjects. American College of Physicians. Ann Intern Med; 1989 Nov; 111(10):843-8. PubMed ID: 2683918 [No Abstract] [Full Text] [Related]
37. Gene-splice oversight. Parens E Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331 [No Abstract] [Full Text] [Related]
39. The paradoxical case of payment as benefit to research subjects. Macklin R IRB; 1989; 11(6):1-3. PubMed ID: 11650284 [No Abstract] [Full Text] [Related]
40. Informed consent in the clinical research setting: experimentation on human subjects. Owens JF Med Trial Tech Q; 1987; 33(3):335-50. PubMed ID: 11653829 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]